About Accumol

picture

Accumol was founded in May 2010 and is a privately-owned biotechnology company based in Calgary.

We are dedicated to providing clinical laboratories with innovative molecular biology reagents, tailored to their specific needs. These reagents are designed from the start to be easily implemented within existing workflows and procedures, and to leverage existing equipment and expertise.

Our Values

Honesty and Respect. We strongly believe that meaningful and sustainable relationships can only be built on mutual trust. We are committed to always dealing with our customers, employees, business partners, and the community in an open, respectful way.

Environmental awareness. All human activities have an impact on our planet ecosystem. We believe it is our moral obligation, and our best interest as a species, to minimize that impact. As a company doing business worldwide, which implies the transportation of goods and people over long distances, we understand that our activities have the potential to result in deleterious effects on the environment. We pledge to do everything possible to minimize our environmental impact, and in particular our carbon footprint. By minimizing business travel, encouraging employees to work from home, or choosing the most efficient shipping solutions, we are committed to playing our part for a sustainable future.

Quick Links

 

News

New Publication
March 2021
HLA. 2021;97:183-187
A one‐step assay for sorted CD3+ cell purity and chimerism after hematopoietic stem cell transplantation.
Desoutter et al.

New Publication
December 2019
Biomed J Sci & Tech Res 23(5)-2019
Assessment of the Purity of Isolated CD3+ T Cell Populations by A New Molecular Biology Technology: Impact on the Quantification of Chimerism Monitoring After Hematopoietic Stem Cell Transplantation.
Pedini et al.

qPCR kits released!
April 25, 2017
The Non-T and Non-B Genomic Detection kits are now available for quantitative PCR (real-time PCR) instruments. In addition, we are pleased to introduce the brand new qPCR Non-Myeloid Genomic Detection kit, designed to assess the purity of Myeloid cell preparations directly at the DNA level.

New Publication
January 2015
British Journal of Haematology, 2015, 168, 26–37

picture

Applications